My topic, unsurprisingly, will be the regulatory agenda facing the insurance industry. I approach this, however, with an appreciation that for many in the industry this regulatory agenda – at a European level at least – has a high degree of uncertainty, probably more so than when I last spoke here.
This is, of course, due to the difficulties facing final agreement on the Solvency II package of directives and regulations, so let me in fact start there, with a discussion of the prospects of Solvency II.